PN

Prashant Narsingrao Biradar

Active Director Director DIN 11086698
DIN 11086698 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Prashant Narsingrao Biradar

Data last updated:

Prashant Narsingrao Biradar is a Director at Bhalkeshwar Pharma Private Limited (since 2025).

DIN 11086698
Primary Designation Director
First Appointment 28 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bhalkeshwar Pharma Private Limited U46497KA2025PTC203459
Director28 May 20252025Active

Directorship timeline

Open interactive timeline →
Bhalkeshwar Pharma Private Limited
Premium access

Shareholding and investment profile for Prashant Narsingrao Biradar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prashant Narsingrao Biradar

Prashant Narsingrao Biradar currently holds 1 directorship: Bhalkeshwar Pharma Private Limited (Director, since 28 May 2025).

Prashant Narsingrao Biradar was first appointed on 28 May 2025 as Director at Bhalkeshwar Pharma Private Limited.

The current boards of Prashant Narsingrao Biradar's companies include Amar Tukade (Bhalkeshwar Pharma Private Limited), Krutika Kishanrao Salunkhe (Bhalkeshwar Pharma Private Limited), Namrata (Bhalkeshwar Pharma Private Limited), Neeta Vinayakrao Shinde (Bhalkeshwar Pharma Private Limited), Umesh Bhalke (Bhalkeshwar Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available